FCGR3A and HIV infectious disease: In both chronic HIV infection and cancer, NK cell recognition of abnormal cells through those activating receptors is defective, mainly as a result of chronic exposure to the respective ligands, which results in persistent down-modulation of NCRs, NKG2D, and CD16 on NK cells.